R Nardone1,2,3, Y Höller1,3, P B Langthaler1,3,4, P Lochner2, S Golaszewski1,3, K Schwenker1,3, F Brigo2,5, E Trinka1,3. 1. Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University and Center for Cognitive Neuroscience, Salzburg, Austria. 2. Department of Neurology, Franz Tappeiner Hospital, Merano, Italy. 3. Spinal Cord Injury and Tissue Regeneration Center, Paracelsus Medical University, Salzburg, Austria. 4. Department of Mathematics, Paris Lodron University of Salzburg, Salzburg, Austria. 5. Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
Abstract
STUDY DESIGN: Repetitive transcranial magnetic stimulation study. OBJECTIVES: The analgesic effects of repetitive transcranial magnetic stimulation (rTMS) in chronic pain have been the focus of several studies. In particular, rTMS of the premotor cortex/dorsolateral prefrontal cortex (PMC/DLPFC) changes pain perception in healthy subjects and has analgesic effects in acute postoperative pain, as well as in fibromyalgia patients. However, its effect on neuropathic pain in patients with traumatic spinal cord injury (SCI) has not been assessed. SETTING: Merano (Italy) and Salzburg (Austria). METHODS: In this study, we performed PMC/DLPFC rTMS in subjects with SCI and neuropathic pain. Twelve subjects with chronic cervical or thoracic SCI were randomized to receive 1250 pulses at 10 Hz rTMS (n=6) or sham rTMS (n=6) treatment for 10 sessions over 2 weeks. The visual analog scale, the sensory and affective pain rating indices of the McGill Pain Questionnaire (MPQ), the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale were used to assed pain and mood at baseline (T0), 1 day after the first week of treatment (T1), 1 day (T2), 1 week (T3) and 1 month (T4) after the last intervention. RESULTS: Subjects who received active rTMS had a statistically significant reduction in pain symptoms in comparison with their baseline pain, whereas sham rTMS participants had a non-significant change in daily pain from their baseline pain. CONCLUSION: The findings of this preliminary study in a small patient sample suggest that rTMS of the PMC/DLPFC may be effective in relieving neuropathic pain in SCI patients.
RCT Entities:
STUDY DESIGN: Repetitive transcranial magnetic stimulation study. OBJECTIVES: The analgesic effects of repetitive transcranial magnetic stimulation (rTMS) in chronic pain have been the focus of several studies. In particular, rTMS of the premotor cortex/dorsolateral prefrontal cortex (PMC/DLPFC) changes pain perception in healthy subjects and has analgesic effects in acute postoperative pain, as well as in fibromyalgiapatients. However, its effect on neuropathic pain in patients with traumatic spinal cord injury (SCI) has not been assessed. SETTING: Merano (Italy) and Salzburg (Austria). METHODS: In this study, we performed PMC/DLPFC rTMS in subjects with SCI and neuropathic pain. Twelve subjects with chronic cervical or thoracic SCI were randomized to receive 1250 pulses at 10 Hz rTMS (n=6) or sham rTMS (n=6) treatment for 10 sessions over 2 weeks. The visual analog scale, the sensory and affective pain rating indices of the McGill Pain Questionnaire (MPQ), the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale were used to assed pain and mood at baseline (T0), 1 day after the first week of treatment (T1), 1 day (T2), 1 week (T3) and 1 month (T4) after the last intervention. RESULTS: Subjects who received active rTMS had a statistically significant reduction in pain symptoms in comparison with their baseline pain, whereas sham rTMS participants had a non-significant change in daily pain from their baseline pain. CONCLUSION: The findings of this preliminary study in a small patient sample suggest that rTMS of the PMC/DLPFC may be effective in relieving neuropathic pain in SCI patients.
Authors: Demetrio Ortega Rumi; Wagner F Gattaz; Sergio Paulo Rigonatti; Moacyr Alexandro Rosa; Felipe Fregni; Marina Odebrecht Rosa; Carlos Mansur; Martin Luiz Myczkowski; Ricardo Alberto Moreno; Marco Antonio Marcolin Journal: Biol Psychiatry Date: 2005-01-15 Impact factor: 13.382
Authors: Peter Stanwell; Philip Siddall; Nirmal Keshava; Daniel Cocuzzo; Saadallah Ramadan; Alexander Lin; David Herbert; Ashley Craig; Yvonne Tran; James Middleton; Shiva Gautam; Michael Cousins; Carolyn Mountford Journal: Neuroimage Date: 2010-06-30 Impact factor: 6.556
Authors: Max M Klein; Roi Treister; Tommi Raij; Alvaro Pascual-Leone; Lawrence Park; Turo Nurmikko; Fred Lenz; Jean-Pascal Lefaucheur; Magdalena Lang; Mark Hallett; Michael Fox; Merit Cudkowicz; Ann Costello; Daniel B Carr; Samar S Ayache; Anne Louise Oaklander Journal: Pain Date: 2015-09 Impact factor: 7.926
Authors: Nikolaos Koutsouleris; Thomas Wobrock; Birgit Guse; Berthold Langguth; Michael Landgrebe; Peter Eichhammer; Elmar Frank; Joachim Cordes; Wolfgang Wölwer; Francesco Musso; Georg Winterer; Wolfgang Gaebel; Göran Hajak; Christian Ohmann; Pablo E Verde; Marcella Rietschel; Raees Ahmed; William G Honer; Dominic Dwyer; Farhad Ghaseminejad; Peter Dechent; Berend Malchow; Peter M Kreuzer; Tim B Poeppl; Thomas Schneider-Axmann; Peter Falkai; Alkomiet Hasan Journal: Schizophr Bull Date: 2018-08-20 Impact factor: 9.306
Authors: Eldon Loh; Magdalena Mirkowski; Alexandria Roa Agudelo; David J Allison; Brooke Benton; Thomas N Bryce; Sara Guilcher; Tara Jeji; Anna Kras-Dupuis; Denise Kreutzwiser; Oda Lanizi; Gary Lee-Tai-Fuy; James W Middleton; Dwight E Moulin; Colleen O'Connell; Steve Orenczuk; Patrick Potter; Christine Short; Robert Teasell; Andrea Townson; Eva Widerström-Noga; Dalton L Wolfe; Nancy Xia; Swati Mehta Journal: Spinal Cord Date: 2022-02-05 Impact factor: 2.473